Biohaven Therapeutics Ltd.
NYSE BHVN · New Haven, CT
Works in Cardiovascular · Genetic & rare · Hematology · Immunology · Metabolic & endocrine · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Women's health
Biohaven Therapeutics Ltd. is a clinical trial sponsor based in New Haven, CT, listed as NYSE BHVN. It has 15 active clinical trials with 5,017 planned participants, across 11 therapeutic areas. Since 2021 it has completed 13 trials and stopped 3 early.
Trial track record · since 2021
Financials · NYSE BHVN
Fundraising
Pipeline · 15 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Biohaven Therapeutics Ltd
Biohaven Therapeutics Ltd is lead sponsor of 15 active clinical trials on ClinicalTrials.gov, with 5,017 planned participants, in Cardiovascular, Genetic & rare, Hematology, Immunology and other areas. Since 2021 it has completed 13 trials and stopped 3 early.
Biohaven Therapeutics Ltd is based in New Haven, CT and is listed as NYSE BHVN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Biohaven Therapeutics Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-14.
Approve Suite is not affiliated with Biohaven Therapeutics Ltd.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.